Ophthalmic Sciences

Company Overview

Snapshot

Founded in August 2019, Ophthalmic Sciences operates with 1–10 employees. The company has raised $2.32 million across three funding rounds from two investors. In November 2022, Ophthalmic Sciences initiated recruitment for clinical testing of its advanced prototype at Assuta Hashalom, a significant step in its product development.

Business overview

Ophthalmic Sciences develops the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device for in-home telemedicine. This mobile product utilizes a VR-like headset and artificial intelligence algorithms to analyze captured video imaging, providing fast, reliable, and user-friendly IOP measurements, a critical biomarker for glaucoma monitoring and treatment. The company's tonometer solution enables highly accurate asynchronous remote monitoring, aiming to improve patient outcomes and reduce costs for clinics, hospitals, and telehealth providers in the Health Tech & Life Sciences sector.

Strategic signal

In November 2022, Ophthalmic Sciences initiated recruitment for clinical testing of its most advanced prototype at Assuta Hashalom, one of the country's busiest eye clinics. This development signals a critical advancement in the company's product validation and moves it closer to potential market entry, demonstrating progress in its clinical development pipeline to investors.

Company Intelligence Q&A

What is the primary product developed by Ophthalmic Sciences?

Ophthalmic Sciences has developed the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device designed for in-home telemedicine.

When did Ophthalmic Sciences begin clinical study recruitment for its IOPerfect device?

In November 2022, Ophthalmic Sciences initiated recruitment at Assuta Hashalom for the clinical testing of its most advanced prototype.

What technology does the IOPerfect device utilize for measurement?

The IOPerfect uses a VR-like headset and artificial intelligence algorithms to analyze captured video imaging for fast and reliable intraocular pressure measurement.

What is the total capital raised by Ophthalmic Sciences?

Ophthalmic Sciences has raised a total of $2.32 million across three funding rounds.

Which investor has participated in funding rounds for Ophthalmic Sciences?

eHealth Ventures has participated as an investor in funding rounds for Ophthalmic Sciences, including a Seed round in January 2022.